Organisation paid for research Program year 2025 Source: CMS Open Payments

Cliniverse Research LLC

Neither a doctor nor a teaching hospital

Research payments

$1,047,126

529 payments

Through program year 2025, Cliniverse Research LLC is reported as receiving $1,047,126 in research payments, across 529 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$663,790	343
2024	Research	$372,136	185
2023	Research	$11,200	1

Breakdown

Who paid Research payments · program years 2023–2025

Bausch Health US, LLC $460,648 316 payments
ITI, Inc. $448,047 188 payments
Genzyme Corporation $63,891 10 payments
Chiesi USA, Inc. $27,300 2 payments
Daiichi Sankyo Inc. $22,270 5 payments
ACADIA Pharmaceuticals Inc $19,800 7 payments
Genentech, Inc. $5,170 1 payment

Studies the money was for Research payments · program years 2023–2025

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis (RED-C-3132) $460,648 316 payments
Iti-007-602 $288,872 142 payments
Iti-007-601 $117,435 37 payments
A Randomized, Double-Blind, Placebo Controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients With Uncontrolled Moderate to Severe Asthma $63,891 10 payments
A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD (TRITON) $27,300 2 payments
Iti-007-421 $23,740 5 payments
Ds7011-107 $22,270 5 payments
Acp-204-006 $19,800 7 payments
Iti-007-321 $18,000 4 payments
Rvt-3101-201 (Tahoe) $5,170 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.